2011 "Buzz of BIO" (Healing) Winner

Watch Amrita Therapeutics' CEO Susan K. Finston's presentation at the 2011 BIO Business Forum (June 2011):

Based in Ahmedabad, Gujarat, Amrita Therapeutics is a biotechnology start-up company developing novel drugs and devices to combat cancer and other leading public health threats of the 21st century. Amrita Therapeutics new therapies and hybrid devices will provide more effective alternatives for treatment of cervical cancer, viral, and multi-resistant bacterial infections by designing the products of bacteria to defend the human body against more than one disease simultaneously, utilizing or interfering in multiple pathways or mechanisms.

As the first bio-pharmaceutical discovery company to focus explicitly on multiple disease targeting, or MDT, drug development, Amrita Therapeutics' new therapies will be characterized by fewer side-effects, less likelihood of drug resistance, and will come to market at costs substantially below industry average.

Amrita Therapeutics proprietary science platform may usher in a new golden age of drug development, akin to the early antibiotic era.